686
Views
64
CrossRef citations to date
0
Altmetric
Reviews

Clostridium difficile infection: molecular pathogenesis and novel therapeutics

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jianfeng Wang, Chu Yang, Chao Zhang, Xiaoyan Mao & An Lizhe. (2021) Complete genome sequence of the Clostridium difficile LCL126. Bioengineered 12:1, pages 745-754.
Read now
Shanlin Ke, Nira R. Pollock, Xu-Wen Wang, Xinhua Chen, Kaitlyn Daugherty, Qianyun Lin, Hua Xu, Kevin W. Garey, Anne J. Gonzales-Luna, Ciarán P. Kelly & Yang-Yu Liu. (2021) Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection. Gut Microbes 13:1.
Read now

Articles from other publishers (62)

Marco Bocchetti, Maria Grazia Ferraro, Federica Melisi, Piera Grisolia, Marianna Scrima, Alessia Maria Cossu & Tung On Yau. (2023) Overview of current detection methods and microRNA potential in Clostridioides difficile infection screening . World Journal of Gastroenterology 29:22, pages 3385-3399.
Crossref
Ankit Singh Tanwar, Padival ShrupthaApoorva JnanaAngela Brand, Mamatha BallalKapaettu Satyamoorthy & Thokur Sreepathy Murali. (2023) Emerging Pathogens in Planetary Health and Lessons from Comparative Genome Analyses of Three Clostridia Species . OMICS: A Journal of Integrative Biology 27:6, pages 247-259.
Crossref
Matthew M. Guilleman, Brenna A. Y. Stevens, Laura P. Van Lieshout, Amira D. Rghei, Yanlong Pei, Lisa A. Santry, Brad Thompson & Sarah K. Wootton. (2021) AAV-mediated delivery of actoxumab and bezlotoxumab results in serum and mucosal antibody concentrations that provide protection from C. difficile toxin challenge. Gene Therapy 30:5, pages 455-462.
Crossref
Dileep Francis, Anusha Bhairaddy, Atheene Joy, Gopika Veeramanickathadathil Hari & Ashik Francis. 2023. Secretory Proteins. Secretory Proteins 271 350 .
Afifa, Nazim Hussain & Zulqarnain Baqar. 2023. Microbial Biomolecules. Microbial Biomolecules 375 403 .
Theresa Enkirch, Sara Mernelius, Cecilia Magnusson, Sharon Kühlmann‐Berenzon, Malin Bengnér, Thomas Åkerlund & Kristina Rizzardi. (2022) Molecular epidemiology of community‐ and hospital‐associated Clostridioides difficile infections in Jönköping, Sweden, October 2017 – March 2018 . APMIS 130:11, pages 661-670.
Crossref
Hamideh Raeisi, Masoumeh Azimirad, Ali Nabavi-Rad, Hamid Asadzadeh Aghdaei, Abbas Yadegar & Mohammad Reza Zali. (2022) Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective. Frontiers in Immunology 13.
Crossref
Bilal Ahmed Abbasi, Aishwarya Dharan, Astha Mishra, Devansh Saraf, Irsad Ahamad, Prashanth Suravajhala & Jayaraman Valadi. (2022) In Silico Characterization of Uncharacterized Proteins From Multiple Strains of Clostridium Difficile. Frontiers in Genetics 13.
Crossref
Hiroyuki Kunishima, Hiroki Ohge, Hiromichi Suzuki, Atsushi Nakamura, Kazuaki Matsumoto, Hiroshige Mikamo, Nobuaki Mori, Yoshitomo Morinaga, Katsunori Yanagihara, Yuka Yamagishi & Sadako Yoshizawa. (2022) Japanese Clinical Practice Guidelines for Management of Clostridioides (Clostridium) difficile infection. Journal of Infection and Chemotherapy 28:8, pages 1045-1083.
Crossref
Emma R. Guiberson, Christopher J. Good, Aaron G. Wexler, Eric P. Skaar, Jeffrey M. Spraggins & Richard M. Caprioli. (2022) Multimodal Imaging Mass Spectrometry of Murine Gastrointestinal Tract with Retained Luminal Content. Journal of the American Society for Mass Spectrometry 33:6, pages 1073-1076.
Crossref
Seçil Abay, Emral Fevzi Ahmed, Fuat Aydin, Emre Karakaya & Hamit Kaan Müştak. (2022) Presence of Clostridioides difficile in cattle feces, carcasses, and slaughterhouses: Molecular characterization and antibacterial susceptibility of the recovered isolates. Anaerobe 75, pages 102575.
Crossref
Shilpa Borehalli Mayegowda, Manjula NG, Saad Alghamdi, Banan Atwah, Zain Alhindi & Fahadul Islam. (2022) Role of Antimicrobial Drug in the Development of Potential Therapeutics. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-17.
Crossref
Marina Di Domenico, Andrea Ballini, Mariarosaria Boccellino, Salvatore Scacco, Roberto Lovero, Ioannis Alexandros Charitos & Luigi Santacroce. (2022) The Intestinal Microbiota May Be a Potential Theranostic Tool for Personalized Medicine. Journal of Personalized Medicine 12:4, pages 523.
Crossref
Ariana R Tagliaferri, Kelsey Murray & Patrick Michael. (2022) A Case of Pseudomembranous Colitis of Unknown Etiology. Cureus.
Crossref
Bilal Wajid, Faria Anwar, Imran Wajid, Haseeb Nisar, Sharoze Meraj, Ali Zafar, Mustafa Kamal Al-Shawaqfeh, Ali Riza Ekti, Asia Khatoon & Jan S. Suchodolski. (2021) Music of metagenomics—a review of its applications, analysis pipeline, and associated tools. Functional & Integrative Genomics 22:1, pages 3-26.
Crossref
Dhrati V. Patangia, Cornelius Anthony Ryan, Eugene Dempsey, Reynolds Paul Ross & Catherine Stanton. (2022) Impact of antibiotics on the human microbiome and consequences for host health. MicrobiologyOpen 11:1.
Crossref
Jessica Penney, Jenna Wick, Tinzar Basein & Shira Doron. 2022. Infection Prevention. Infection Prevention 181 191 .
Mackingsley Kushan Dassanayake, Teng-Jin Khoo & Jia An. (2021) Antibiotic resistance modifying ability of phytoextracts in anthrax biological agent Bacillus anthracis and emerging superbugs: a review of synergistic mechanisms. Annals of Clinical Microbiology and Antimicrobials 20:1.
Crossref
Suha A. AL-FakharSaad Hasan Mohammed AliKhalil Ismail A. MohammedWifaq M. AliJinan M. Mousa. (2021) Detection of Closteridium difficile in patients with Hematological Malignancies: A Stool Based Immunochromatographic study. Research Journal of Pharmacy and Technology, pages 5010-5014.
Crossref
Sirirak Arthithanyaroj, Surang Chankhamhaengdecha, Urai Chaisri, Ratchaneewan Aunpad & Amornrat Aroonnual. (2021) Effective inhibition of Clostridioides difficile by the novel peptide CM-A. PLOS ONE 16:9, pages e0257431.
Crossref
Dan Nicolae Păduraru, Daniel Ion, Mihai Dumitrașcu, Răzvan Petca, Aida Petca, Florica Șandru, Octavian Andronic, Georgiana Radu & Alexandra Bolocan. (2021) Clostridium difficile infection characteristics in a general surgery clinic . Experimental and Therapeutic Medicine 22:4.
Crossref
Mélanie Bourgin, Aicha Kriaa, Héla Mkaouar, Vincent Mariaule, Amin Jablaoui, Emmanuelle Maguin & Moez Rhimi. (2021) Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health. Microorganisms 9:6, pages 1122.
Crossref
Venugopal Bhaskara, Maria Trinidad Leal, Jacqueline Seigner, Theresa Friedrich, Emanuel Kreidl, Elisabeth Gadermaier, Manfred Tesarz, Azra Rogalli, Laura Stangl, Jacqueline Wallwitz, Katharina Hammel, Mario Rothbauer, Herwig Moll, Peter Ertl, Rainer Hahn, Gottfried Himmler, Anton Bauer & Emilio Casanova. (2021) Efficient production of recombinant secretory IgA against Clostridium difficile toxins in CHO-K1 cells. Journal of Biotechnology 331, pages 1-13.
Crossref
Akram Baghani, Mahmood Alimohammadi, Amir Aliramezani, Maliheh Talebi, Alireza Mesdaghinia & Masoumeh Douraghi. (2020) Isolation and characterization of a multidrug-resistant Clostridioides difficile toxinotype V from municipal wastewater treatment plant. Journal of Environmental Health Science and Engineering 18:2, pages 1281-1288.
Crossref
John H. Moore, Armita Salahi, Carlos Honrado, Christopher Warburton, Cirle A. Warren & Nathan S. Swami. (2020) Quantifying bacterial spore germination by single-cell impedance cytometry for assessment of host microbiota susceptibility to Clostridioides difficile infection. Biosensors and Bioelectronics 166, pages 112440.
Crossref
Masaru Tanaka, Sakura Onizuka, Riko Mishima & Jiro Nakayama. (2020) Cultural isolation of spore-forming bacteria in human feces using bile acids. Scientific Reports 10:1.
Crossref
Swetha Parvataneni & Avinash R. Dasari. (2020) Zinc Level and Its Role in Recurrent Clostridium difficile Infection: A Case Report and Literature Review . Journal of Investigative Medicine High Impact Case Reports 8, pages 232470962094131.
Crossref
Elvira Garza-González, Soraya Mendoza-Olazarán, Rayo Morfin-Otero, Andrea Ramírez-Fontes, Patricia Rodríguez-Zulueta, Samantha Flores-Treviño, Paola Bocanegra-Ibarias, Héctor Maldonado-Garza & Adrián Camacho-Ortiz. (2019) Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) vs. FMT Enriched with Lactobacillus in the Treatment of Recurrent Clostridioides difficile Infection . Canadian Journal of Gastroenterology and Hepatology 2019, pages 1-7.
Crossref
Robert G. Nichols, Jeffrey M. Peters & Andrew D. Patterson. (2019) Interplay Between the Host, the Human Microbiome, and Drug Metabolism. Human Genomics 13:1.
Crossref
Alex J. Forero, Marina Muñoz, Milena Camargo, Sara C. Soto-De León, Dora I. Ríos-Chaparro, Claudia Birchenall, Darío Pinilla, Juan M. Pardo, Diego F. Josa, Manuel A. Patarroyo & Juan D. Ramírez. (2019) High frequency of toxigenic Clostridium difficile and Clostridium perfringens coinfection among diarrheic patients at health care facility-onset (HCFO) and community-onset (CO) centers in Bogotá, Colombia. Gut Pathogens 11:1.
Crossref
Deyan Luo, Xuechao Liu, Li Xing, Yakun Sun, Jie Huang, Liangyan Zhang, Jiajia Li & Hui Wang. (2019) Immunogenicity and Protection from Receptor-Binding Domains of Toxins as Potential Vaccine Candidates for Clostridium difficile. Vaccines 7:4, pages 180.
Crossref
Marina Muñoz, Daniel Restrepo-Montoya, Nitin Kumar, Gregorio Iraola, Milena Camargo, Diana Díaz-Arévalo, Nelly S. Roa-Molina, Mayra A. Tellez, Giovanny Herrera, Dora I. Ríos-Chaparro, Claudia Birchenall, Darío Pinilla, Juan M. Pardo-Oviedo, Giovanni Rodríguez-Leguizamón, Diego F. Josa, Trevor D. Lawley, Manuel A. Patarroyo & Juan David Ramírez. (2019) Integrated genomic epidemiology and phenotypic profiling of Clostridium difficile across intra-hospital and community populations in Colombia. Scientific Reports 9:1.
Crossref
Michiel Kleerebezem, Sylvie Binda, Peter A Bron, Gabriele Gross, Colin Hill, Johan ET van Hylckama Vlieg, Sarah Lebeer, Reetta Satokari & Arthur C Ouwehand. (2019) Understanding mode of action can drive the translational pipeline towards more reliable health benefits for probiotics. Current Opinion in Biotechnology 56, pages 55-60.
Crossref
Adeyinka C. Adejumo, Olalekan Akanbi & Lydie Pani. (2019) Among inpatients, ischemic bowel disease predisposes to Clostridium difficile infection with concomitant higher mortality and worse outcomes. European Journal of Gastroenterology & Hepatology 31:1, pages 109-115.
Crossref
Huimin Deng, Siqi Yang, Yucheng Zhang, Kai Qian, Zhaohui Zhang, Yangyang Liu, Ye Wang, Yang Bai, Hongying Fan, Xinmei Zhao & Fachao Zhi. (2018) Bacteroides fragilis Prevents Clostridium difficile Infection in a Mouse Model by Restoring Gut Barrier and Microbiome Regulation. Frontiers in Microbiology 9.
Crossref
Francisco A. Uzal, Mauricio A. Navarro, Jihong Li, John C. Freedman, Archana Shrestha & Bruce A. McClane. (2018) Comparative pathogenesis of enteric clostridial infections in humans and animals. Anaerobe 53, pages 11-20.
Crossref
Travis J. Kochan, Matthew H. Foley, Michelle S. Shoshiev, Madeline J. Somers, Paul E. Carlson & Philip C. Hanna. (2018) Updates to Clostridium difficile Spore Germination. Journal of Bacteriology 200:16.
Crossref
Wichuda Phothichaisri, Puey Ounjai, Tanaporn Phetruen, Tavan Janvilisri, Pongsak Khunrae, Sombat Singhakaew, Piyada Wangroongsarb & Surang Chankhamhaengdecha. (2018) Characterization of Bacteriophages Infecting Clinical Isolates of Clostridium difficile. Frontiers in Microbiology 9.
Crossref
Xiao-shu Liu, Wen-ge Li, Wen-zhu Zhang, Yuan Wu & Jin-xing Lu. (2018) Molecular Characterization of Clostridium difficile Isolates in China From 2010 to 2015. Frontiers in Microbiology 9.
Crossref
Eric W. Jones & Jean M. Carlson. (2018) In silico analysis of antibiotic-induced Clostridium difficile infection: Remediation techniques and biological adaptations. PLOS Computational Biology 14:2, pages e1006001.
Crossref
Marina Muñoz, Dora I. Ríos-Chaparro, Giovanny Herrera, Sara C. Soto-De Leon, Claudia Birchenall, Darío Pinilla, Juan M. Pardo-Oviedo, Diego F. Josa, Manuel A. Patarroyo & Juan D. Ramírez. (2018) New Insights into Clostridium difficile (CD) Infection in Latin America: Novel Description of Toxigenic Profiles of Diarrhea-Associated to CD in Bogotá, Colombia. Frontiers in Microbiology 9.
Crossref
Jenna Wick, Tinzar Basein & Shira Doron. 2018. Infection Prevention. Infection Prevention 153 162 .
Adrián Camacho-Ortiz, Eva María Gutiérrez-Delgado, Jose F. Garcia-Mazcorro, Soraya Mendoza-Olazarán, Adrián Martínez-Meléndez, Laura Palau-Davila, Simon D. Baines, Héctor Maldonado-Garza & Elvira Garza-González. (2017) Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome. PLOS ONE 12:12, pages e0189768.
Crossref
Marina Muñoz, Milena Camargo, Dora Inés Ríos-Chaparro, Paula Gómez, Manuel Alfonso Patarroyo & Juan David Ramírez. (2017) Community-acquired infection with hypervirulent Clostridium difficile isolates that carry different toxin and antibiotic resistance loci: a case report. Gut Pathogens 9:1.
Crossref
Bonita Durnaś, Ewelina Piktel, Marzena Wątek, Tomasz Wollny, Stanisław Góźdź, Jolanta Smok-Kalwat, Katarzyna Niemirowicz, Paul B. Savage & Robert Bucki. (2017) Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo. BMC Microbiology 17:1.
Crossref
Eun Jin KimSung Hyun LeeHann TchahEell Ryoo. (2017) Effect of Metronidazole in Infants with Bowel Habit Change: Irrelative to the Clostridium difficile Colonization . Pediatric Gastroenterology, Hepatology & Nutrition 20:1, pages 47.
Crossref
Adrián Martínez-Meléndez, Adrián Camacho-Ortiz, Rayo Morfin-Otero, Héctor Jesús Maldonado-Garza, Licet Villarreal-Treviño & Elvira Garza-González. (2017) Current knowledge on the laboratory diagnosis of Clostridium difficile infection . World Journal of Gastroenterology 23:9, pages 1552.
Crossref
Mariana Berho & Pablo A. Bejarano. 2017. Colon, Rectum and Anus: Anatomic, Physiologic and Diagnostic Bases for Disease Management. Colon, Rectum and Anus: Anatomic, Physiologic and Diagnostic Bases for Disease Management 323 345 .
Anshul Sood & Chetana Vaishnavi. (2016) Non-antibiotic management for Clostridium difficile infection . Journal of Gastrointestinal Infections 6:1, pages 3-11.
Crossref
Peter Warn, Pia Thommes, Abdul Sattar, David Corbett, Amy Flattery, Zuo Zhang, Todd Black, Lorraine D. Hernandez & Alex G. Therien. (2016) Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin. Antimicrobial Agents and Chemotherapy 60:11, pages 6471-6482.
Crossref
Jesse A. Jones, Emily Price, Donovan Miller & Kirk E. Hevener. (2016) A simplified protocol for high-yield expression and purification of bacterial topoisomerase I. Protein Expression and Purification 124, pages 32-40.
Crossref
Chen Lidan, Li Linhai, Liao Yang, Sun Zhaohui, Huang Xiaoyan & Shi Yuling. (2016) Molecular characterization and antimicrobial susceptibility of tcdA-negative Clostridium difficile isolates from Guangzhou, China. Diagnostic Microbiology and Infectious Disease 84:4, pages 361-365.
Crossref
Carl T. Gustafson, Felix Boakye-Agyeman, Cassandra L. Brinkman, Joel M. Reid, Robin Patel, Zeljko Bajzer, Mahrokh Dadsetan & Michael J. Yaszemski. (2016) Controlled Delivery of Vancomycin via Charged Hydrogels. PLOS ONE 11:1, pages e0146401.
Crossref
Yong Duk Jeon, Namki HongJung Ho KimSe Hee ParkSung Bae KimIn Ji SongHea Won AnnJin Young AhnSun Bean KimNam Su KuKyungwon LeeDongeun YongJune Myung KimJun Yong Choi. (2016) Fecal Transplantation using a Nasoenteric Tube during an Initial Episode of Severe Clostridium difficile Infection . Infection & Chemotherapy 48:1, pages 31.
Crossref
. 2016. Molecular Microbiology. Molecular Microbiology 663 682 .
SungSook Choi, HaeKyung Lee, JiHan Yu & HiunSuk Chae. (2015) In vitro augmented photodynamic bactericidal activity of tetracycline and chitosan against Clostridium difficile KCTC5009 in the planktonic cultures. Journal of Photochemistry and Photobiology B: Biology 153, pages 7-12.
Crossref
Xingmin Sun & Simon A. Hirota. (2015) The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection. Molecular Immunology 63:2, pages 193-202.
Crossref
Jingguo Li, Lei Yin, Guanglei Qiu, Xue Li, Qing Liu & Jianping Xie. (2015) A photo-bactericidal thin film composite membrane for forward osmosis. Journal of Materials Chemistry A 3:13, pages 6781-6786.
Crossref
Mariana Berho & Pablo A.Bejarano. 2016. Coloproctology. Coloproctology 1 24 .
Kevin T Kavanagh, Lindsay E Calderon, Daniel M Saman & Said K Abusalem. (2014) The use of surveillance and preventative measures for methicillin-resistant staphylococcus aureus infections in surgical patients. Antimicrobial Resistance and Infection Control 3:1.
Crossref
William R Brown. (2014) Fecal microbiota transplantation in treating Clostridium difficile infection . Journal of Digestive Diseases 15:8, pages 405-408.
Crossref
Peter M. Keller & Marko H. Weber. (2014) Rational Therapy of <b><i>Clostridium difficile</i></b> Infections. Visceral Medicine 30:5, pages 304-309.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.